(89)Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP) - A novel diagnostic and staging modality for localized and metastatic urothelial carcinoma

Pravin Viswambaram; Mohammed Al-Zubaidi; Steve McCombie; Richard Gauci; Elizabeth Liow; Thomas Ferguson; Andrew Redfern; Nat Lenzo; Dickon Hayne

(89)Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP) - A novel diagnostic and staging modality for localized and metastatic urothelial carcinoma

Pravin Viswambaram, Mohammed Al-Zubaidi, Steve McCombie, Richard Gauci, Elizabeth Liow, Thomas Ferguson, Andrew Redfern, Nat Lenzo, Dickon Hayne

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	167-168
Number of pages	2
Journal	BJU International
Volume	129
Publication status	Published - Jun 2022
Event	Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand - Gold Coast, Australia Duration: 25 Jun 2022 → 28 Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{072ea5f3a0834eb784a33b5bc007deb2,

title = "(89)Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP) - A novel diagnostic and staging modality for localized and metastatic urothelial carcinoma",

author = "Pravin Viswambaram and Mohammed Al-Zubaidi and Steve McCombie and Richard Gauci and Elizabeth Liow and Thomas Ferguson and Andrew Redfern and Nat Lenzo and Dickon Hayne",

year = "2022",

month = jun,

language = "English",

volume = "129",

pages = "167--168",

journal = "BJU International",

issn = "1464-4096",

publisher = "John Wiley & Sons",

note = "Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand ; Conference date: 25-06-2022 Through 28-06-2022",

}

(89)Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP) - A novel diagnostic and staging modality for localized and metastatic urothelial carcinoma. / Viswambaram, Pravin; Al-Zubaidi, Mohammed; McCombie, Steve et al.
In: BJU International, Vol. 129, 06.2022, p. 167-168.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - (89)Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP) - A novel diagnostic and staging modality for localized and metastatic urothelial carcinoma

AU - Viswambaram, Pravin

AU - Al-Zubaidi, Mohammed

AU - McCombie, Steve

AU - Gauci, Richard

AU - Liow, Elizabeth

AU - Ferguson, Thomas

AU - Redfern, Andrew

AU - Lenzo, Nat

AU - Hayne, Dickon

PY - 2022/6

Y1 - 2022/6

M3 - Abstract/Meeting Abstract

SN - 1464-4096

VL - 129

SP - 167

EP - 168

JO - BJU International

JF - BJU International

T2 - Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand

Y2 - 25 June 2022 through 28 June 2022

ER -